NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00265824,Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM),https://clinicaltrials.gov/study/NCT00265824,DREAM,COMPLETED,PURPOSE: This randomized phase III trial is studying maintenance therapy with bevacizumab alone after an induction therapy combining bevacizumab+chemotherapy to see how well they work compared to maintenance therapy with bevacizumab+erlotinib alone after an induction therapy combining bevacizumab+chemotherapy in treating patients with metastatic colorectal cancer that cannot be removed by surgery.,NO,Colorectal Cancer,"DRUG: bevacizumab|DRUG: bevacizumab, erlotinib","Progression-free survival during maintenance therapy, Tumor evaluation every 2 months",,,GERCOR - Multidisciplinary Oncology Cooperative Group,,ALL,"ADULT, OLDER_ADULT",PHASE3,700,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CDR0000453861|GERCOR-C04-2|EU-20565|GERCOR-OPTIMOX3|GERCOR-DREAM- C04-2,2005-05,2012-03,,2005-12-15,,2015-12-11,"LKH Leoben, Leoben, 8700, Austria|LKH Steyr, Steyr, 4400, Austria|Klinikum Wels-Grieskirchen GmbH, Wels, 4600, Austria|AKH Universitätsklinik für Innere Medizin I, Wien, 1090, Austria|Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, H7M 3L9, Canada|Cité de la Santé de Laval, Laval, Quebec, H7M 3L9, Canada|CHUM Hôpital Notre-Dame, Montreal, Quebec, H2L 4M1, Canada|Mc Gill University Hospital, Montreal, Quebec, H2W 1S6, Canada|Hôpital Charles LeMoyne, Montreal, Quebec, J4V 2H1, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec, H1T 2M4, Canada|Centre Hospitalier, Antibes, 06606, France|Centre Hospitalier, Auxerre, 89011, France|Centre Hospitalier, Beauvais, 60000, France|Hôpital Avicenne, Bobigny, 93000, France|Polyclinique Bordeaux Nord, Bordeaux, 33000, France|Centre Hospitalier, Briey, 54140, France|Hôpital Pasteur, Colmar, 68024, France|Centre Hospitalier, Dax, 40100, France|Hopital Drevon, Dijon, 21000, France|CHD les oudairies, La Roche sur Yon, 85000, France|Clinique Victor Hugo, Le Mans, F-72000, France|Hopital Robert Boulin, Libourne, 33500, France|CHU Dupuytren, Limoges, 87000, France|Centre Hospitalier Saint Joseph Saint Luc, Lyon, 69007, France|Hôpital Privé Jean Mermoz, Lyon, 69008, France|Clinique de la sauvegarde, Lyon, 69009, France|hôpital Ambroise Paré, Marseille, 13000, France|Institu Paoli Calmette, Marseille, 13000, France|Centre Hospitalier, Meaux, 77100, France|Clinique Claude BERNARD, Metz, 57070, France|Centre hospitalier Layné, Mont de Marsan, 40000, France|Centre Hospitalier Intercommunal Le Raincy - Montfermeil, Montfermeil, 93370, France|centre oncologie de Gentilly, Nancy, 54100, France|Centre Catherine de Sienne, Nantes, 44000, France|Institut Curie, Paris, 75005, France|Groupe Hospitalier les Diaconnesses, Paris, 75012, France|Hôpital Pitié Salpêtrière, Paris, 75013, France|Hôpital Saint Joseph, Paris, 75014, France|Institut Mutualiste Montsouris, Paris, 75014, France|Hopital Saint Antoine, Paris, 75571, France|Hopital Tenon, Paris, 75970, France|centre Catalan oncologie, Perpignan, 66000, France|Clinique Armoricaine, Saint Brieuc, 22000, France|Centre Hospitalier, Semur en Auxois, 21140, France|C.H. Senlis, Senlis, 60309, France|Hopital Foch, Suresnes, 92151, France|Clinique Générale, Valence, 26000, France",
